Julphar Introduces the Latest Technology in Continuous Glucose Monitoring Dexcom G5 Mobile to UAE

As part of its commitment to changing diabetic issues care and administration by delivering best-in- course solutions, Gulf Pharmaceutical Industries (Julphar) will certainly present Dexcom G5 Mobile Continual Sugar Monitoring (CGM) System in a satellite seminar during the International Diabetes Federation (IDF) congress kept in Abu Dhabi, 4 th -8 th of December, chaired by Dr. Abdel Razzaq Madani, President of the Emirates Diabetic Society and presented by Dr. Saleh Adi, Director of Madison Clinic for Pediatric Diabetes (USA) and Dr. Lars Krinelke, Director or Medical Affairs (Dexcom). The symposium will certainly focus on the sensible and clinical application of continuous glucose surveillance (CGM) with extensive insulin-requiring people especially with the attributes of the current Dexcom G5 System offered in UAE.

The Dexcom G5 is the first and fully mobile CGM system approved by the FDA and with CE marking for both adults and children as young as 2 years of age that sends glucose data straight to a suitable smart device both apple and android platforms, freeing users from the need to carry a separate receiver.

Dexcom G5 Mobile users can also select as much as 5 marked recipients, or " followers who can from another location keep track of a client'' s glucose info and get alert notices from virtually anywhere.

The Dexcom G5 Mobile CGM System showcases the most exact sugar sensing unit on the market while giving boosted mobility and flexibility to view and share personal glucose data and patterns. The only CGM with single digit MARD (Mean Absolute Relative Difference), the Dexcom G5 Mobile provides customizable notifies and an integrated low sugar alarm system (55 mg/dL alarm system) to warn individuals of low and high and just how rapidly they could be taking place through a simplified mobile user interface.